{"id":515175,"date":"2021-07-20T10:47:49","date_gmt":"2021-07-20T14:47:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/"},"modified":"2021-07-20T10:47:49","modified_gmt":"2021-07-20T14:47:49","slug":"abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/","title":{"rendered":"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, July  20, 2021  (GLOBE NEWSWIRE) &#8212; Abraham, Fruchter &amp; Twersky LLP announces the filing of a class action lawsuit on behalf of investors who purchased Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ:ATHA) common stock between September 18, 2020 and June 17, 2021, or in connection with Athira\u2019s September 2020 initial public offering (\u201cIPO\u201d).<\/p>\n<p align=\"justify\">\n        <strong>If you wish to discuss this class action or obtain more information about your rights, please contact Abraham, Fruchter &amp; Twersky LLP by e-mailing Jack G. Fruchter (<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3Xp0xBhPeoM3L1OF_u68z2XnWgHiPaZz6Fo5raW5hpgVAzshjC3KTaSvQFHJMYsv6n51tMXORpZiTw5tKi5ETaXO6Kbgpy1wuX77fKCntYA=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong>JFruchter@aftlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>) or Sean M. Handron-O\u2019Brien (<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BKyc_9335zS5IyX6ZKd2ZLdy-1-1P_ro3jNknxIk-9nXXJki6KoOdxUH6d9EMSHpJIg7GC7W5FqB8UKEqfmxSHZRccL8Zgais3u-MoCdNI4=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong>SHandronobrien@aftlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>). You may also call (212) 279-5050.<\/strong>\u00a0\u00a0<\/p>\n<p align=\"justify\">In September 2020, Athira conducted its IPO, selling 12 million shares of common stock priced at $17.00 per share. Then, on June 17, 2021, Athira announced that the Company\u2019s board had placed its President and Chief Executive Officer, Leen Kawas, on leave pending a review of claims of potential research misconduct \u201cstemming from research Dr. Kawas conducted while at Washington State University.\u201d Following this news, Athira\u2019s stock price fell $7.09 per share, or over 38%, to close at $11.15 per share on June 18, 2021.<\/p>\n<p align=\"justify\">Abraham, Fruchter &amp; Twersky LLP is a law firm based in New York and maintaining an office in California. The firm\u2019s attorneys have extensive experience litigating on behalf of shareholders and consumers in class action litigations involving corporate misconduct and has been ranked as a leading plaintiffs\u2019 securities litigation firm in the 2020 survey by ISS Securities Class Action Services. Please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lf1-fMcmMLtIIVRZWjYOtwW5VY90zwdlV1RWikJWwm8smbHt8qoJyxSUG6zX6be32UMYVke2_634hud-uYswAg==\" rel=\"nofollow noopener\" target=\"_blank\">www.aftlaw.com<\/a> for more information.<\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong>\n      <\/p>\n<p align=\"justify\">Abraham, Fruchter &amp; Twersky LLP<br \/>Jack G. Fruchter | <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3Xp0xBhPeoM3L1OF_u68z3Rb8U1RmrbTRiURsKJiwj-EeQCbd5EZHft9TXUJrjXz7Pzdu-s9svSz5Awvju5LkvhdqB6ILKGdcnyi45P6CzQ=\" rel=\"nofollow noopener\" target=\"_blank\">JFruchter@aftlaw.com<\/a><br \/>Sean M. Handron-O\u2019Brien | <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BKyc_9335zS5IyX6ZKd2ZLdy-1-1P_ro3jNknxIk-9m6vRb-QmQ-NF1QqSX4xSqPxV1E1UajtQZ_wJAiBNBmMCVVlGXwI3IvbSjdZdNinoI=\" rel=\"nofollow noopener\" target=\"_blank\">SHandronobrien@aftlaw.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ce5ca23a-b069-42e3-a5a1-1db43b982841\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, July 20, 2021 (GLOBE NEWSWIRE) &#8212; Abraham, Fruchter &amp; Twersky LLP announces the filing of a class action lawsuit on behalf of investors who purchased Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ:ATHA) common stock between September 18, 2020 and June 17, 2021, or in connection with Athira\u2019s September 2020 initial public offering (\u201cIPO\u201d). If you wish to discuss this class action or obtain more information about your rights, please contact Abraham, Fruchter &amp; Twersky LLP by e-mailing Jack G. Fruchter ( JFruchter@aftlaw.com ) or Sean M. Handron-O\u2019Brien ( SHandronobrien@aftlaw.com ). You may also call (212) 279-5050.\u00a0\u00a0 In September 2020, Athira conducted its IPO, selling 12 million shares of common stock priced at $17.00 per share. Then, on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-515175","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 20, 2021 (GLOBE NEWSWIRE) &#8212; Abraham, Fruchter &amp; Twersky LLP announces the filing of a class action lawsuit on behalf of investors who purchased Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ:ATHA) common stock between September 18, 2020 and June 17, 2021, or in connection with Athira\u2019s September 2020 initial public offering (\u201cIPO\u201d). If you wish to discuss this class action or obtain more information about your rights, please contact Abraham, Fruchter &amp; Twersky LLP by e-mailing Jack G. Fruchter ( JFruchter@aftlaw.com ) or Sean M. Handron-O\u2019Brien ( SHandronobrien@aftlaw.com ). You may also call (212) 279-5050.\u00a0\u00a0 In September 2020, Athira conducted its IPO, selling 12 million shares of common stock priced at $17.00 per share. Then, on &hellip; Continue reading &quot;Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-20T14:47:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA)\",\"datePublished\":\"2021-07-20T14:47:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/\"},\"wordCount\":280,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/\",\"name\":\"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=\",\"datePublished\":\"2021-07-20T14:47:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/","og_locale":"en_US","og_type":"article","og_title":"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA) - Market Newsdesk","og_description":"NEW YORK, July 20, 2021 (GLOBE NEWSWIRE) &#8212; Abraham, Fruchter &amp; Twersky LLP announces the filing of a class action lawsuit on behalf of investors who purchased Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ:ATHA) common stock between September 18, 2020 and June 17, 2021, or in connection with Athira\u2019s September 2020 initial public offering (\u201cIPO\u201d). If you wish to discuss this class action or obtain more information about your rights, please contact Abraham, Fruchter &amp; Twersky LLP by e-mailing Jack G. Fruchter ( JFruchter@aftlaw.com ) or Sean M. Handron-O\u2019Brien ( SHandronobrien@aftlaw.com ). You may also call (212) 279-5050.\u00a0\u00a0 In September 2020, Athira conducted its IPO, selling 12 million shares of common stock priced at $17.00 per share. Then, on &hellip; Continue reading \"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-20T14:47:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA)","datePublished":"2021-07-20T14:47:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/"},"wordCount":280,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/","name":"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=","datePublished":"2021-07-20T14:47:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MzU1OCM0MzA1OTA4IzIwODgxNzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abraham-fruchter-twersky-llp-announces-the-filing-of-a-class-action-lawsuit-on-behalf-of-investors-of-athira-pharma-inc-nasdaqatha\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Abraham, Fruchter &amp; Twersky LLP Announces the Filing of a Class Action Lawsuit on Behalf of Investors of Athira Pharma, Inc. (NASDAQ:ATHA)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=515175"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515175\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=515175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=515175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=515175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}